10 Eyebrow Thinning Patterns Associated With Specific Hormonal Conditions
3. Polycystic Ovary Syndrome (PCOS) and Androgenic Alopecia Patterns

Polycystic Ovary Syndrome (PCOS), affecting up to 10% of women of reproductive age, creates a unique eyebrow thinning pattern characterized by androgenic influences that mirror male-pattern baldness but manifest in the eyebrow region. The elevated androgen levels, particularly dihydrotestosterone (DHT) and testosterone, that define PCOS create a distinctive thinning pattern that typically affects the central and inner portions of the eyebrows more severely than the outer regions. This pattern occurs because eyebrow follicles in these areas contain higher concentrations of 5-alpha reductase, the enzyme responsible for converting testosterone to the more potent DHT, which directly miniaturizes hair follicles. Women with PCOS often experience what researchers term "androgenic eyebrow recession," where the inner corners of the eyebrows gradually thin and recede, creating a gap between the eyebrows and the inner canthi of the eyes. This thinning is frequently accompanied by coarsening of remaining eyebrow hairs and increased growth of unwanted facial hair in other areas, creating a paradoxical situation where hair is simultaneously lost in desired locations and gained in unwanted ones. The severity of eyebrow thinning in PCOS patients often correlates with other androgenic symptoms, including acne, male-pattern scalp hair loss, and hirsutism. Research has shown that women with PCOS who have higher free androgen index scores tend to experience more pronounced eyebrow changes, making this pattern a useful clinical marker for assessing the severity of androgenic effects. Treatment approaches focusing on androgen reduction, such as spironolactone, metformin, or hormonal contraceptives, can help slow progression and sometimes reverse early-stage thinning, though complete restoration may require additional interventions such as topical minoxidil or eyebrow transplantation procedures.